Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Minden

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Leukemia|July 2, 2003
Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcomeE Kolomietz, P Marrano, K Yee, et al.
The American Journal of Surgical Pathology|December 1, 1987
Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantationS J Urbanski, A E Kossakowska, J Curtis, et al.
Cell|February 9, 1990
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor geneE A Rose, T Glaser, C Jones, et al.
Bone Marrow Transplantation|July 3, 2007
Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioningY Zaretsky, J Rifkind, G Lockwood, et al.
Blood|April 18, 1998
High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phaseJ C Wang, T Lapidot, J D Cashman, et al.
Blood|February 15, 1996
Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisisC Sirard, T Lapidot, J Vormoor, et al.
Investigational New Drugs|April 16, 2011
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemiaH M Kantarjian, S Padmanabhan, W Stock, et al.
Nature Communications|April 12, 2023
Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesisN Zioni, A Akhiad Bercovich, N Chapal-Ilani, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Leukemia|July 2, 2003
Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcomeE Kolomietz, P Marrano, K Yee, et al.
The American Journal of Surgical Pathology|December 1, 1987
Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantationS J Urbanski, A E Kossakowska, J Curtis, et al.
Cell|February 9, 1990
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor geneE A Rose, T Glaser, C Jones, et al.
Bone Marrow Transplantation|July 3, 2007
Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioningY Zaretsky, J Rifkind, G Lockwood, et al.
Blood|April 18, 1998
High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phaseJ C Wang, T Lapidot, J D Cashman, et al.
Blood|February 15, 1996
Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisisC Sirard, T Lapidot, J Vormoor, et al.
Investigational New Drugs|April 16, 2011
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemiaH M Kantarjian, S Padmanabhan, W Stock, et al.
Nature Communications|April 12, 2023
Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesisN Zioni, A Akhiad Bercovich, N Chapal-Ilani, et al.
Pageof 7